Schaumburg, Ill., United States: Launched 14 critical injectable medicines since Company inception in October 2023 and remains on track to meet target of 25+ products by year-end 2025 Pursuing two-pronged portfolio development strategy to establish strong foundation of critical injectable products while ensuring long-term competitiveness and return on investment …
